News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Coherent launched PhotonLink, an integrated optics platform for AI datacenters, and expects revenue ramp beginning Q4 2026.
  • Anaptys reported Q2 strength with Jemperli net sales up 34% to $644 million, boosting revenue and net income.
  • The FDA set a PDUFA action date of February 2027 for Jemperli in rectal cancer.
  • newcleo closed a $247 million SPAC business combination and will begin trading on Nasdaq as NWCL on September 22, 2026.
  • Abivax raised €767.1 million in a US offering, completed a royalty buy-back, and extended cash runway into Q4 2029.
  • Gauzy received a Nasdaq delisting notice for sub-$1 share price and missed filings and said it will appeal.

Latest Articles

Truist Lowers Norwegian Cruise Line Rating as Promotional Pressure Mounts

Truist Lowers Norwegian Cruise Line Rating as Promotional Pressure Mounts

Truist Securities cut its rating on Norwegian Cruise Line Holdings to Hold from Buy, noting the stock's proximity to the firm's $20 price target and increased promotional activity across the mass-market cruise segment. The bank's July demand and price survey, along with discussions with senior industry executives and forward booking and pricing dat…

CSX Shares Jump After Quarterly Beat, Raised Full-Year Outlook

CSX Shares Jump After Quarterly Beat, Raised Full-Year Outlook

CSX Corp. rallied in morning trading after releasing second-quarter 2026 results that topped estimates on both earnings and revenue and came with an upgraded full-year outlook. The Jacksonville-based freight railroad reported EPS of $0.54 versus a consensus near $0.51, and a quarterly revenue record of $3.94 billion, up 10% year-over-year. Manageme…

Lumentum: Buy the AI-Driven Dip — A Tactical Mid-Term Long

Lumentum: Buy the AI-Driven Dip — A Tactical Mid-Term Long

Lumentum (LITE) looks like a front-line beneficiary of the AI infrastructure buildout. The stock has pulled back from its run, offering a dip-buying window for traders who accept valuation risk. We lay out a mid-term trade with entry, stop, and target prices and explain why hyperscaler capex, Nvidia strategic commitments, and a factory ramp make $L…

Oslo Stocks Close Higher; OBX Reaches One-Month Peak

Oslo Stocks Close Higher; OBX Reaches One-Month Peak

Norway's equity market finished higher on Thursday, with the Oslo OBX index advancing 1.08% to a one-month high. Gains in energy, fertilizer and defense-related stocks led the rise, while a small group of firms in geophysical services, consumer goods and semiconductors recorded the day's heaviest declines. Commodity prices and currency pairs also m…

DOJ Announces Tighter, Faster Path for Some Merger Reviews

DOJ Announces Tighter, Faster Path for Some Merger Reviews

The U.S. Department of Justice antitrust division said on July 23 it will streamline its merger review procedures, a step that could shorten clearance timelines for a subset of deals. The change allows the DOJ to request fewer documents up front for certain transactions while retaining the authority to demand further materials later. The move comes…

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships

Jyong Biotech Ltd., a Nasdaq-listed Taiwanese biotechnology company, reaffirmed its global licensing partnership strategy to address the expanding Benign Prostatic Hyperplasia (BPH) market. The company is advancing its botanical drug candidate, Botreso®, currently in Phase III clinical trials in the US and Taiwan, aiming to provide safer, long-term…

Agility Robotics Names Michael Beer as CFO; Churchill Capital XI Shares Dip

Agility Robotics Names Michael Beer as CFO; Churchill Capital XI Shares Dip

Shares of Churchill Capital Corp XI (NASDAQ: CCXI) declined 3.5% after Agility Robotics announced the appointment of Michael Beer as its chief financial officer in advance of a planned public listing via a business combination with CCXI. The move is part of a broader leadership realignment that transitions Jennifer Hunter to a sole Chief Operating …

Rivian Options Signal 9.2% Move Around July 30 Earnings

Rivian Options Signal 9.2% Move Around July 30 Earnings

Options market activity prices in a 9.2% move for Rivian Automotive Inc. Class A when the company reports quarterly results on July 30 after the market close, according to Bloomberg options data. The stock has historically moved both more and less than the implied magnitude across recent earnings, exceeding the implied move in five of the past eigh…

IAMGOLD Reborn: A Swing Trade on Production and Cashflow Momentum

IAMGOLD Reborn: A Swing Trade on Production and Cashflow Momentum

IAMGOLD reported a dramatic operational rebound: record 2025 production, bumper margins driven by realized gold prices near $4,859/oz, and strong free cash flow. The market cap sits near $9.1B while enterprise value is roughly $8.6B, leaving room for multiple expansion if growth continues. This idea is a mid-term swing trade to capture continued re…

Options Point to 4% Move for Stellantis When Earnings Hit July 30

Options Point to 4% Move for Stellantis When Earnings Hit July 30

Options-derived estimates compiled by Bloomberg indicate Stellantis NV shares could move about 4% when the automaker releases quarterly results on July 30 before markets open. Historical earnings-day behavior for the stock has been uneven: in five of the last eight reporting events the actual share move exceeded the options-implied figure.

Sen. Cassidy Signals Backing for Erica Schwartz's CDC Nomination

Sen. Cassidy Signals Backing for Erica Schwartz's CDC Nomination

Senate Health, Education, Labor, and Pensions Committee Chair Bill Cassidy said he intends to vote to move Erica Schwartz's nomination for Centers for Disease Control and Prevention director forward. Schwartz was nominated by President Donald Trump. Cassidy called her capable in an opening statement at the committee meeting, adjourned the panel and…

Canada pledges firm response as U.S. tariff threat looms

Canada pledges firm response as U.S. tariff threat looms

Canadian Prime Minister Mark Carney told provincial premiers that Ottawa is intensifying negotiations with the United States and will take necessary measures to defend workers, farmers, businesses and families after President Trump warned of new 50% tariffs on $20 billion of Canadian goods. Provinces are split on response, with Alberta and Saskatch…

Options Signal 6.4% Move for Amazon Ahead of July 30 Earnings

Options Signal 6.4% Move for Amazon Ahead of July 30 Earnings

Options pricing points to a 6.4% implied move for Amazon when the company reports earnings on July 30 after the market close, according to data compiled by Bloomberg. Historically, Amazon's actual stock reactions around earnings have often exceeded those implied moves, with six of the last eight reports producing larger-than-expected swings.